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Abstract: Enteral feeding is the preferred method of nutrient provision for preterm infants. Though
parenteral nutrition remains an alternative to provide critical nutrition after preterm delivery, the
literature suggests that enteral feeding still confers significant nutritional and non-nutritional benefits.
Therefore, the purpose of this narrative review is to summarize health and clinical benefits of early
enteral feeding within the first month of life in preterm infants. Likewise, this review also proposes
methods to improve enteral delivery in clinical care, including a proposal for decision-making
of initiation and advancement of enteral feeding. An extensive literature review assessed enteral
studies in preterm infants with subsequent outcomes. The findings support the early initiation and
advancement of enteral feeding impact preterm infant health by enhancing micronutrient delivery,
promoting intestinal development and maturation, stimulating microbiome development, reducing
inflammation, and enhancing brain growth and neurodevelopment. Clinicians must consider these
short- and long-term implications when caring for preterm infants.
Keywords: enteral; feeding; preterm; nutrition; growth; development
1. Introduction
Appropriate nutrition and growth are critical therapies for the preterm infant popula-
tion. Multiple studies have concluded that early and higher nutrient provision influences
growth and clinical outcomes in preterm infants, such as neurodevelopment, prevention
of bronchopulmonary dysplasia (BPD), or decreased risk of retinopathy of prematurity
(ROP) [1–5]. A growth-related study by Ehrenkranz et al. explicitly quantified that increas-
ing quartiles for weight gain for extremely low birth weight infants was associated with
improved neurodevelopmental outcomes at 18 months of age [1]. Early postnatal nutrition
delivery must be prioritized, as increased energy and protein intakes solely during the
first week of life have been associated with long-term neurodevelopment [2]. However,
when considering most optimal sources of nutrition for preterm infants, the provision of
mother’s own milk is the recommended choice [6]. Multiple benefits have been described,
with examples including enhanced immunity and a reduced risk of necrotizing enterocoli-
tis (NEC), BPD, late onset sepsis, and ROP in preterm infants [7–9]. While the literature
strongly supports provision of adequate nutrition, there is evidence that additional benefit
is conferred when enterally provided compared to parenterally. Therefore, the purpose
of this narrative review is to summarize benefits of enteral feeding in preterm infants
(<37 weeks gestation) during the first one month of life (Table 1).
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Table 1. Benefits and risks of early life enteral feeding practices in preterm infants.
Enteral Feeding Practice Benefits Risks
1. Start enteral feeding as soon
as feasible following
preterm birth [10,11]
◦ Use of the gastrointestinal tract is
physiologic to the intrauterine
environment [12]
◦ Prevents villous atrophy and decreases
intestinal permeability [13–15]
◦ Favorably influences intestinal
microbiome [16]
◦ Reduces risk of developing systemic
inflammation [17]
◦ Decreases risk of developing
comorbidities (e.g., retinopathy of
prematurity, bronchopulmonary
dysplasia [17]
• May need to utilize alternative
substrate (e.g., donor human milk
or preterm infant formula) to
prevent fasting if no maternal milk
immediately available [18]
• As with older populations [19],
consider potential implications of
enteral feeding in hemodynamically
unstable infants
2. Trophic enteral feeding
Þ Brief duration (≤72 h)
Þ Extended duration (>72 h)
◦ Promotes neurologic and physiologic gut
maturity [20–22]
◦ Possible decrease in dysmotility of
prematurity [20]
◦ Brief duration: Decreases time to achieve
full volume enteral feedings [23,24]
◦ Extended duration: Strategy previously
implemented in infants born <750 g to
reduce necrotizing enterocolitis
risk [25,26], though there are no
unanimous recommendations for the
most clinically advantageous trophic
feeding duration
• Brief duration: Less evidence
available for application in a
population of infants born <750 g or
at the limits of viability [23]
• Extended duration: Inadequate
evidence to show clear benefit for
infants >750 g [27]
3. Start and advance enteral
feeding by 30–40 mL/kg/day
to goal volume [23]
◦ Evidenced-based practice [23]
◦ When fortified, may provide higher
micronutrient provision in early life [28]
◦ Decreases risk of infection [23]
◦ Decreases duration of parenteral
nutrition use and need for central
line [24]
◦ Higher enteral provision enhances brain
growth and potential cognitive
outcomes [29,30]
◦ Higher early enteral provision decreases
risk of developing comorbidities [31]
• Less evidence available for
application in a population of
infants born <750 g or at the limits
of viability [23]
4. Early human milk
fortification [32,33]
◦ Increases micronutrient provision [28]
◦ Enhances energy and protein provision
as parenteral nutrition provision is
decreased (a contributing period to
suboptimal growth [34])
• Increases feeding osmolality [35]
2. Review of the Literature
As this was not a systematic review or meta-analysis, literature was reviewed as
available and applicable to early life enteral feeding in preterm infants. Though recently
published articles were preferable, less recent publications were included, if relevant.
Literature results are summarized as a narrative review.
2.1. Enteral Nutrient Provision
Early enteral feeding provides vital nutrients and promotes necessary growth in
preterm infants. Though priority may often be on adequacy of total energy and protein
provision for these infants, adequate delivery of micronutrients (including 13 vitamins
and multiple minerals) also remains essential to promote optimal physical growth and
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neurodevelopment [36]. Early delivery of enteral feeding may markedly increase overall
provision of essential micronutrients via fortification or nutrient supplementation com-
pared to parenteral nutrition alone, especially if parenteral additive shortages exist [37].
In addition, parenteral micronutrient formulations may not provide sufficient amounts
for preterm infants receiving total parenteral nutrition. In the example of vitamin D,
joint guidelines for parenteral provision are 200–1000 International Units (IU) per day (or
80–400 IU/kilogram(kg)/day) [38]. However, recommendations may not be met by ex-
tremely low birth weight infants who only receive 120 IU/day based on dosing instructions
for standard parenteral multivitamin formulations [37]. Consequently, enteral provision
becomes the most feasible alternative to enhance delivery, with human milk fortification
able to be initiated at enteral volumes as low as 20 milliliters/kg/day (mL/kg/day) or
at first feeding [32,33], though the addition of such will increase enteral feeding osmolal-
ity [35]. Higher collective provisions of multiple micronutrients (e.g., calcium, phosphorus,
vitamin D) via early initiation and attainment of full enteral feeding theoretically supports
appropriate postnatal growth [28], such as bone mineralization. Given that 80% of bone
mineralization occurs in the third trimester of fetal development [39], optimizing the provi-
sion of these nutrients in the first one month of life is crucial, as this accounts for one third
of this vital period.
Benefits conferred to preterm infants by providing mother’s own milk compared to
preterm infant formula or heat-processed donor human milk has been analyzed [7,40–42].
However, beyond these considerations, early enteral feeding also allows for the supple-
mentation of essential nutrients not standardly added to parenteral nutrition formulations.
One example is iron, which is associated with improved hematological status and may
have implications related to neurodevelopment in preterm infants [43,44]. Though the
age of starting supplementation may vary, initiation at 2 weeks of life may reduce the
need for transfusion and later iron-deficiency anemia [45,46]. Thus, neonates receiving
minimal enteral feeding in the first month of life will not receive early benefit from this
critical nutrient.
Further benefit of early enteral feeding is provision of nutrients not deemed essential
for life but having potential to impact health. Carotenoids are one example of non-essential
micronutrients found in human milk or infant formula, including lutein which concen-
trates in brain and eye tissue at levels dependent on dietary intake [47,48]. An enteral
supplementation trial of lutein in infants born <33 weeks gestation (n = 203) reported
that among infants with retinopathy, fewer supplemented infants progressed to severe
stages (8 vs. 28%) [49]. As this nutrient is not included or available as a parenteral nutrition
additive, enteral feeding becomes the only method of delivery, with provision increasing
parallel to higher volume of enteral intake. Furthermore, these nutrients may have cu-
mulative effects on retinal development [50], so the most benefit will be attained by early
initiation and progressive advancement of enteral feeding after preterm birth.
2.2. Gastrointestinal Development
Preterm infants are born with incomplete organ development, including the intestinal
tract, as evidenced in Figure 1.
However, in utero, the fetal gastrointestinal tract remains in use, with the fetus es-
timated to swallow amniotic fluid at 200–250 mL/kg/day of weight [12]. In addition to
enzymes and electrolytes, amniotic fluid also contains growth hormones, carbohydrates,
proteins, and lipids [12]. Therefore, nutrients from the swallowed amniotic fluid support
fetal growth, as well as the proliferation of the intestinal epithelial cells. However, preterm
birth disrupts this normal physiology, with intestinal development further hindered by late
provision of enteral feeding [12]. In animal and human studies, exclusive parenteral nutri-
tion provision increases intestinal villous atrophy—as demonstrated in Figure 2—which is
reversed with enteral feeding provision [13,14].
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Figure 1. Cross Section Stain of Villi in the Ileum of Preterm (A) vs. Term (B) Piglets. Figure reproduced from Frontiers
in Immunology, Vol. 9, Page 5 as available via Open Access and under terms of the Creative Commons Attribution
License. Original article published as “Preterm Life in Sterile Conditions: A Study on Preterm, Germ-Free Piglets” by
Splichalova et al., 2018 [51].
Figure 2. A Macroscopic Appearance and Stained Cross Section of Distal Small Intestine in Preterm
Piglets Receiving Enteral Feeding vs. Total Parenteral Nutrition (TPN). Figure modified and re-
produced with copyright permission from American Journal of Physiology-Gastrointestinal and Liver
Physiology, Vol. 302, page 221, Copyright © 2012 by The American Physiological Society. Original ar-
ticle published as “Enteral Bile Acid Treatment Improves Parenteral Nutrition-Related Liver Disease
and Intestinal Mucosal Atrophy in Neonatal Pigs” by Jain et al. [52].
Findings thus support early enteral feeding, with a Cochrane review further conclud-
ing no increased risk of NEC in infants born <28 weeks gestation or <1500 g by initiating
enteral feeding within the first four days of life [10]. With further consideration to NEC,
the American Society for Parenteral and Enteral Nutrition (ASPEN) recommends starting
minimal enteral feeding within the first two days of life for infants ≥1000 g [11]. For
infants receiving enteral feeding but in need of blood transfusion, a 2019 Cochrane review
concluded there is insufficient evidence to indicate if holding enteral feeding has any effect
on developing NEC [53]. Similarly, monitoring gastric residuals is not necessary as an
assessment of feeding tolerance to prevent NEC, as a 2019 Cochrane review found no
benefit to this practice [54]. Continuing enteral feeding also remains feasible and safe for
infants receiving Indomethacin as a treatment for patent ductus arteriosus [55,56]. Delayed
introduction of feeding, discontinuation of enteral feeding, prolonged trophic feeding, and
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slow enteral advancement only results in longer duration for achieving full-volume enteral
feeding [10,23]. Enteral feeding was previously advanced by 15–20 mL/kg/day, but a 2017
Cochrane review indicates that more rapid advancement by 30–40 mL/kg/day does not
increase risk of adverse outcomes in very or extremely low birth weight infants [23].
In combination with preventing intestinal villous atrophy, early enteral feedings in
preterm infants also promotes intestinal development. In examples from a piglet model,
Hansen et al. compared intestinal outcomes for preterm-born piglets between two groups:
group 1 received parenteral nutrition only for the first 5 days of life and group 2 received
minimal volume enteral trophic feedings for the first 5 days in addition to parenteral nutri-
tion. Significant results showed that relative to body weight, intestinal weight was higher in
the enterally fed group (p < 0.001) [57], theorized to be associated with enhanced intestinal
development. Similarly, lack of enteral feeding may promote increased permeability of
the intestine, which could include pathogenic organisms. In the example from mice, lack
of enteral feeding and exclusive parenteral nutrition provision increases risk of bacterial
translocation [13]. Clinical evidence from a 2017 Cochrane meta-analysis of very low birth
weight infants (n = 3753) reported slow enteral advancement to result in “borderline in-
creased risk of invasive infection”, Relative Risk (RR) 1.15 (though 95%Confidence Interval
(CI) 1.00–1.32) [23]. Comparatively, Shulman et al. compared intestinal permeability in
infants born 26–30 weeks gestation (n = 132), in which differences were assessed in infants
started on minimal enteral feeding at 4 vs. 15 days of life [15]. Results identified that
intestinal permeability was lower at 10 days of life in early-fed infants (p < 0.01) [15],
supporting the theory that early feeding promotes enhanced intestinal development.
Enteral nutrient provision also promotes the maturation of intestinal function and hor-
mones in infants following preterm birth. For example, research by Berseth and Nordyke as-
sessed intestinal manometry in infants born 26–33 weeks gestation (n = 32) receiving enteral
feeding during the first week of life of either formula or sterile water (at 24 mL/kg/day) in
addition to parenteral nutrition [20]. While both groups showed an initial intestinal motor
response to enteral provision, after 10 days infants receiving formula had less clustered
phasic activity (p < 0.05) and more migrating activity (p < 0.01) during fasting states [20].
Furthermore, Berseth compared gastrointestinal hormones and peptides in a small sub-
set of infants (n = 27) born at 28–32 weeks gestation with enteral feeding initiated early
(3–5 days of life) vs. late (10–14 days of life) [21]. While no differences initially existed,
after 10 days, fasting plasma gastrin (p = 0.03) and gastric inhibitory peptide (p = 0.001)
were significantly higher in early fed infants [21]. After another 10–14 days, gastrin lev-
els also remained significantly higher in early fed infants (p < 0.02) [21]. More recently,
Shanahan et al. analyzed serum intestinal-related hormones in infants born <30 weeks
gestation (n = 64) [22]. The results showed that serum gastric inhibitory peptide (p = 0.001)
and peptide tyrosine tyrosine (peptide YY) (p = 0.0002) on day of life 7 correlated with
percent of nutrition provided enterally, and furthermore with singular enteral fat, carbo-
hydrate, and protein provision (all p < 0.001) [22]. Additionally, a multivariate analysis
found that peptide YY, glucose-dependent insulinotropic peptide, and leptin levels on day
of life 7 were all associated with reduced time to achievement of full enteral feeding (all
p ≤ 0.05) [22].
2.3. Development of the Intestinal Microbiome
The microbiome continually develops throughout the neonatal and pediatric period
and many modifiable and non-modifiable factors contribute to its evolution and diver-
sity. One modifiable factor is enteral feeding, which promotes the growth of bacteria in
the developing gastrointestinal tract of preterm neonates. In example, Dahlgren et al.
compared two groups of infants (total n = 47) born >32 weeks gestation during the first
month of life: one group received enteral feeding and one group exclusively received total
parenteral nutrition. At four weeks of life, the fecal bacterial diversity was significantly
reduced in the parenterally fed group (p < 0.05) [16]. The impact of enteral nutrition on
microbiome development in the preterm infant is complex and not completely understood.
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Development of the intestinal microbiome in terms of bacterial type, amount, and diversity
varies in preterm infants according to type of substrate provided, such as mother’s own
milk, heat-processed donor human milk, or formula. However, it is less understood how
compositional differences within these substrates impact microbiome development, such as
structure of the protein molecules or the type or quantity of fatty acids or prebiotic carbohy-
drates. Yet, additional and less easily modifiable factors must be considered regarding their
impact on microbiome evolution, such as presence of intestinal inflammation or feeding
intolerance. Likewise, the microbiome may also vary according to gestational age and
postnatal age [58–63]. Multiple additional factors may impact the intestinal microbiome,
such as mode of delivery or antibiotic use [64–67].
Consideration of the how the microbiome develops should be of interest to clinicians
caring for preterm infants. Research has attempted to quantify if the microbiome of preterm
infants who develop NEC is altered compared to healthy controls. A recent meta-analysis
reported infants who developed NEC had increased fecal levels of Proteobacteria and
decreased quantities of Firmicutes and Bacteroidetes [68]. More prospectively, a review
by Stiemsma and Michels summarized the interconnection between early microbiome
development and developmental origins of health and disease [69]. Early results from both
animal and human studies have linked intestinal dysbiosis with adverse outcomes in later
life include asthma, allergic disease, obesity, and neurological or behavioral variations [69].
Ultimately, findings suggest that strategies to optimize the intestinal and microbiota health
of these fragile infants may be beneficial. Therefore, in addition to enteral feeding promot-
ing a healthy microbiome, initiation of enteral feeding also poses opportunity to introduce
probiotic supplementation. However, as no unanimous recommendations exist for optimal
probiotic strain, dose, timing of introduction, or length of duration; supplementation must
be evaluated on an individual patient, clinician, or unit level. Risks of supplementation
include bacterial translocation or unidentified adverse implications for future health. Al-
ternatively, a 2014 Cochrane review reports a lower risk of severe NEC (>Stage II), RR
0.43, 95% CI 0.33–0.56 (n = 5529 infants) and mortality, RR 0.65, 95% CI 0.52–0.81 (n = 5112)
in preterm or low birth weight infants given probiotics as compared to those who were
unsupplemented [70]. For those favoring probiotic supplementation, recommendations
have been set forth in a position paper by the European Society for Paediatric Gastroen-
terology, Hepatology, and Nutrition (ESPGHAN) to guide clinical strategies for probiotic
administration and strain selection in preterm infants [71].
2.4. Inflammatory Response and Clinical Comorbidities
Fetuses swallow amniotic fluid in utero [12], so preterm birth interrupts this normal
physiology. If enteral feeding is not initiated after birth, atrophy of the intestinal villous
lining will occur. Further findings identify additional detrimental impacts associated with
delayed initiation of enteral feeding after birth. For instance, Konnikova et al. analyzed out-
comes for infants born <33 weeks gestation, further comparing early vs. late (< vs. >72 h of
life) introduction of enteral feeding after birth [17]. While the late feeding group was born
smaller and more critically ill at baseline, they demonstrated higher blood C-Reactive Pro-
tein levels (p = 0.02) and increased fecal levels of pro-inflammatory interleukin-8 (p < 0.05)
at two weeks of age. After multivariate analysis (adjusting for baseline characteristics,
nutrition, and illness severity), these findings still remained significant. Notably after
multivariate analysis, late enteral feeding was associated with a 4.5-fold increase in chronic
lung disease with oxygen use at 36 weeks gestation (95% CI 1.8–11.5; p = 0.002) and a
2.9-fold increase in any stage of ROP (95% CI 1.1–7.8; p = 0.03) [17]. Within a cohort
consisting only of extremely low birth weight non-growth-restricted infants, late enteral
feeding was associated with a 5.97-fold increase in the odds of developing chronic lung
disease (p = 0.02) [17]. Overall, infants receiving late enteral feeding were more likely to
have two or more comorbidities compared to early fed infants (25 vs. 8%) [17]. Similarly,
Wemhöner et al. analyzed infants born <31 weeks gestation and ≤1500 g (n = 95) to identify
how nutrition differs between infants who developed BPD vs. non-diseased controls [31].
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Results found that, while calorie, protein, and carbohydrate intakes were statistically simi-
lar during the first two weeks of life, infants who developed BPD received a significantly
lower volume of enteral feeding (p < 0.04) [31].
2.5. Neurodevelopment
Increased nutrition provision in the early weeks of life enhance neurodevelopmental
outcomes in preterm infants [2]. However, there may be an advantage to delivering
nutrition enterally compared to parenterally. In example, Tottman et al. assessed enteral
feeding volume, total fluid, and macronutrient intake during the first one week and
one month of life for infants born <30 weeks gestation or <1500 g. Though growth,
total macronutrient, and enteral intakes were statistically similar between boys vs. girls
(n = 478), nutrition-related sex-specific differences were identified [29]. After adjustment
for birth gestational age, NEC, and sepsis, increased quartiles of enteral feeding volume in
mL/kg/day during the first week (p = 0.001) and one month of life (p = 0.01) was associated
with a higher odds of survival without neuroimpairment in girls (but not boys) [29].
Coviello et al. also compared nutritional intakes in the first four weeks of life for infants
born <31 weeks gestation (n = 131) with brain volumes assessed by magnetic resonance
imaging at term equivalent age [30]. After adjusting for cumulative macronutrient intakes,
parenteral nutrition duration, and postnatal growth; increased enteral fat, enteral protein,
and enteral calorie provision was each associated with increased brain volumes in the
cerebellum and basal ganglia (all p < 0.05) [30]. Comparatively, the duration of parenteral
nutrition days was inversely associated with volume of the cerebellum, cortical grey matter,
basal ganglia, and total brain (all p < 0.05), though parenteral macronutrient provision
was not assessed [30]. Cognitive outcomes at two years of age were not associated with
enteral intake during the first four weeks of life in this study, and there was no comparison
between brain volume and developmental outcomes at this timepoint [30].
2.6. Barriers to Early Life Enteral Feedings
Table 2 lists barriers to early life enteral feeding practices in preterm infants, with
suggested strategies to address these barriers.
Table 2. Barriers and strategies to initiating and advancing early life enteral feeding in preterm infants.
Barriers Strategies to Address Barriers
1. Fear of necrotizing enterocolitis or
spontaneous intestinal perforation
 Implementation of an evidenced-based enteral feeding
protocol [24,28,72]
2. Dysmotility of prematurity
 Early use of suppositories or saline enemas [73]
 Decreased use of sedation and paralysis [74]
3. Emesis and/or abdominal fullness [75–78]
 Alternative method of respiratory support than non-invasive
ventilation, if able and appropriate [75,76]
 Nursing intervention (e.g., pull air out of stomach) [75,76]
 Use of continuous drip or every 2 h bolus feedings [77]
 Prolong bolus feeding infusion time [77]
 Modify body positioning [77]
 Use of a hydrolyzed human milk fortifier [77]
 Use of transpyloric tube feeding per medical team discretion [78]
4. High gastric residuals
 Do not routinely check residuals based on limited evidence to support
this practice [54]
5. Hemodynamic instability
 Allow feedings with patent ductus arteriosus, even if receiving
Indomethacin [55,56]
 Develop and implement unit-specific standardized feeding guidelines,
including threshold dosing of medication (e.g., vasopressors, etc.) to
determine if enteral feedings can be initiated and/or continued [28]
Nutrients 2021, 13, 2289 8 of 15
One of the most significant barriers to initiating and advancing enteral feeding in
preterm infants is clinician fear of NEC. As reviewed previously, multiple systematic re-
views and meta-analyses conclude that early enteral feeding initiation and more rapid
progression does not increase risk of NEC and, in contrast, instead promotes better imme-
diate and lasting outcomes for the preterm infant population. Therefore, the best strategy
to address this barrier is implementation of an evidenced-based enteral feeding protocol
within each neonatal care unit [28]. Review of additional clinical practices and protocols
should also be assessed by individual neonatal care units that may have secondary effects
on enteral feeding, such as use of sedation or paralysis that alter gastrointestinal function
and ability to tolerate enteral feeding [74]. These strategies aim to alleviate clinician fear by
implementing proven successful feeding strategies, create consistency of enteral feeding
practices across different providers, and promote a positive “culture change” within neona-
tal care [79]. In example from one level III neonatal care unit, initial implementation of
an enteral feeding protocol for very low birth weight infants yielded significant improve-
ment in clinical outcomes [72]. This protocol was later modified to parallel newfound
evidenced-based practices including enteral feeding initiation within the first day of life,
reduction in the trophic feeding period to 48 h in infants born <28 weeks gestation with
elimination of the trophic feeding period for infants born >28 weeks gestation, earlier
milk fortification (at enteral volumes of 50–60 mL/kg/day) and higher enteral volume
initiation and advancement (30–35 mL/kg/day) [24,80]. Clinical implementation found
this protocol to be feasible and to result in the faster achievement of full enteral feedings,
a decreased need for indwelling central line to deliver parenteral nutrition, and fewer
infants with weights plotting <10th% on the Fenton preterm infant growth curve at time of
discharge [24].
A second barrier to initiating and achieving early enteral feeding is determining
appropriate methods to use among infants born <750 g, given less available evidence
within this population. However, similar strategies and protocols may be implemented
as in older or larger preterm populations, but with some modifications, as suggested in
Figure 3. For example, enteral volume initiation and advancement may be slower in infants
born <750 g, such as with volumes at 15–25 mL/kg/day [81], though some practices may
be even slower [26]. Nonetheless, individualized care must be tailored to meet the medical
needs of each patient while prioritizing nutrition, especially in those born at the limits
of viability.
Concern may exist that the early achievement of full enteral feedings contributes to ac-
celerated growth in this patient population, which contributes to high adiposity. However,
risk of excessive growth may be less concerning during this period than growth failure
and diagnosable malnutrition [82], as evidenced from 2013 data by the Vermont Oxford
Network summarizing that half of very low birth weight infants in North America were
discharged with weights plotting <10th% for age on their respective growth chart [83].
Consequently, experienced clinicians may advocate that establishing full volume enteral
feeding with appropriate fortification in early life actually supports appropriate body
composition by preventing nutrition deficits that cause neonatal growth failure and lin-
ear stunting. In example, Miller et al. reported increased risk of growth failure during
the transition from parenteral to enteral nutrition [34]. Nutrition management during
this transitional period must be carefully evaluated and modified to meet infant needs,
especially given the length of this period may vary significantly based on unit nutrition
protocols, birth weight and/or gestational age, and infant illness severity. Liotto et al.
demonstrated the importance of close observation and monitoring during the transitional
phase, as low protein provision during this period was associated with decreased growth
velocity and fat-free mass composition at term-corrected age in very low birth weight
infants [84]. Likewise, Brennan et al. compared hourly intakes of macronutrients during
the transitional phase, exemplifying the need for higher parenteral volume when enteral
feeding was <40 mL/kg/day as well as early fortification of human milk to achieve tar-
geted protein provision when infants began receiving more enteral compared to parenteral
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nutrition [85]. Thus, initiating and achieving targeted fortification levels (that will achieve
desired micronutrient, energy, and protein goals at targeted enteral volumes) prior to
discontinuation of parenteral nutrition will promote consistent adequate provision of daily
nutrition. This may be most beneficial to the smallest preterm infants who consequently
have the highest nutritional needs [86], yet may require longer time to transition from
parenteral to full enteral nutrition. Enteral feeding fortification is ideally achieved through
provision of human milk with designated human milk fortifiers, provision of preterm
infant formulas (e.g., 24 calorie/ounce), and additional supplementation (e.g., protein
modular or micronutrient supplement) as available and indicated to achieve targeted goals.
Figure 3. Proposed decision making for initiating and advancing enteral feeding in preterm infants.
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Clinical experience suggests catch-up growth is more easily attained for weight than
for linear growth. Thus, stunted lean body mass accretion in early life may not be regained
by term corrected age like weight, and therefore may contribute to a higher proportion of
weight as adipose tissue [87,88]. This concept is exemplified in Figures 4 and 5 which were
constructed to demonstrate growth from 25–40 weeks gestation for an example infant (birth
weight 600 g) on the 2013 Fenton growth curve, with estimated body mass index (BMI)
size plotted on the Olsen BMI Curves for Preterm Infants [89–92]. Figure 4, Example A
demonstrates growth appropriately maintained for weight and length, with corresponding
BMI plotted in Figure 5, Example A. In contrast, Figure 4, Example B demonstrates the
same maintained weight as in Example A, but with linear growth failure in the first one
month of life before establishing maintenance. In Figure 5, Example B shows correlating
BMI as result of early linear growth failure, which is estimated to plot approximately 0.9
standard deviations higher at 40 weeks gestation compared to if linear growth had been
adequately maintained since birth (Example A). While evaluating differences in BMI serves
as an indirect estimate of body composition, alternative measures are more accurate, such
as air displacement plethysmography [93].
Research additionally indicates that delayed enteral feeding after birth promotes
inflammation [17], and inflammation increases risk of both inadequate linear growth and
development of comorbidities (e.g., BPD) [94,95]. These may perpetuate the risk of altered
body composition and therapies to manage comorbidities (e.g., steroid administration) can
further impair linear growth [96]. Conclusively, an early transition to full volume enteral
feedings should be viewed as an ideal therapy to promote appropriate growth and body
composition in preterm infants. Ultimately, clinicians must consider the comprehensive
multi-system short and long-term implications for the management of enteral feeding in
preterm infants, especially within the first one month of life.
Figure 4. Comparison of adequate (Example A) vs. early growth failure (Example B) for linear
growth in an extremely low birth weight infant from 25–40 weeks gestation with adequate weight
gain. Examples A and B 2013 Fenton growth charts constructed and reprinted from the Pedi-
Tools.org website [89,91,92] as available via open access and under terms of the Creative Commons
Attribution License.
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Figure 5. Comparison of body mass index trend from 25–40 weeks gestation in an extremely low
birth weight infant with adequate (Example A) vs. early growth failure (Example B) for linear
growth when weight gain is adequate. Examples A and B modified and reproduced with permission
from first author Irene Olsen, published in Pediatrics, Vol. 135, page 575, Copyright © 2015 by the
American Academy of Pediatrics. Original article published as “BMI Curves for Preterm Infants” by
Olsen et al. [90].
3. Conclusions
Literature supports that enteral feeding, especially early initiation and more rapid
enteral advancement, impact preterm infant health during the first one month of life
by enhancing micronutrient delivery, promoting intestinal development and maturation,
stimulating microbiome development, reducing inflammation, and enhancing brain growth
and neurodevelopment. Clinicians must seriously consider the multi-system short and
long-term implications that result from the management of enteral feeding in preterm
infants and should revise clinical feeding protocols accordingly.
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